Interferon- α 2b reduces phosphorylation and activity of MEK and ERK through a Ras / Raf -independent mechanism
2000
Interferon-α2b and its effects on cell signaling
publication
Author Information
Author(s): Romerio F, Riva A, Zella D
Primary Institution: Institute of Human Virology, University of Maryland Biotechnology Institute
Hypothesis
Does Interferon-α2b reduce the activity of MEK and ERK through a Ras/Raf-independent mechanism?
Conclusion
Interferon-α2b reduces the activity of the MEK/ERK pathway and may enhance anti-cancer effects without affecting Ras and Raf.
Supporting Evidence
- IFN-α2b treatment reduced MEK1 and ERK1/2 activity after 24-48 hours.
- Ras and Raf-1 activities were not affected by IFN-α2b treatment.
- Short-term exposure to IFN-α2b did not impact MEK/ERK activity.
Takeaway
Interferon-α2b helps slow down how fast certain cells grow by changing how they send signals, without using some other proteins.
Methodology
Transformed T- and monocytoid cell lines were treated with recombinant human IFN-α2b and analyzed for MEK and ERK activity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website